The pitch is compelling: a single sample of blood could scan the body for dozens of different cancers at once, catching disease at a stage when it is easier to treat and more likely to be curable. For ...

By Sneha S K March 9 (Reuters) - Bristol Myers Squibb on Monday said its experimental drug for a rare form of blood cancer ...

The biopharmaceutical company on Monday said its proposed drug, oral mezigdomide, used in combination with an existing treatment, carfilzomib and dexamethasone, demonstrated "statistically significant ...

Marie Hindee experienced a breakthrough in her 15-year battle with chronic lymphocytic leukemia and small lymphocytic lymphoma after undergoing a cutting-edge therapy at Corewell Health Beaumont ...

Food ‌and Drug ‌Administration on Thursday approved ​Johnson & Johnson's treatment for a type of ‌blood cancer, ⁠making it ...

Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...

Another challenge facing test designers is that early detection may not necessarily save lives. A crucial factor, and something that is still unknown about the new multi-cancer tests, is whether they ...

A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a ...

MPNs involve overproduction of blood cells, while MDS results in poorly formed cells, affecting blood cell function and counts. Diagnosis requires blood tests, bone marrow biopsy, and genetic testing ...

A one‑year course of T‑DM1 offers excellent cancer‑free survival for early HER2‑positive breast cancer, with far less nerve ...